| Overview |
| bsm-52419r-fitc-100ul |
| Cytokeratin 8 Recombinant Antibody, FITC Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| FITC |
| Rabbit |
| A synthesized peptide derived from human Cytokeratin 8 |
| Recombinant |
| IgG |
| 1mg/ml |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3856 |
| P05787 |
| Cytoplasm, Nucleus |
| card2; Cardiac autoantigen 2 120kD; CK 8; CK8; CK-8; ck8; Cyk 8; cyk8; CYKER; Cytokeratin endo A; Cytokeratin-8; Cytokeratin8; DreK8; EndoA; k0; CYK8; k2c8; K2C8_HUMAN; k8; Keratin 8; Keratin type ii cytoskeletal 8; Keratin, type II cytoskeletal 8; Keratin-8; Keratin8; KO; Krt 2.8; Krt 8; krt8; KRT-8; MGC118110; MGC174782; MGC53564; MGC85764; sb:cb186; Type-II keratin Kb8. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz